PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) shares rose 3.4% on Thursday . The company traded as high as $1.83 and last traded at $1.83. Approximately 200 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 7,040 shares. The stock had previously closed at $1.77.
PureTech Health Stock Performance
The company has a 50-day simple moving average of $1.75 and a 200-day simple moving average of $1.90.
About PureTech Health
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Further Reading
- Five stocks we like better than PureTech Health
- Earnings Per Share Calculator: How to Calculate EPS
- MarketBeat Week in Review – 03/24 – 03/28
- About the Markup Calculator
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What Investors Need to Know About Upcoming IPOs
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
